Hosted on MSN1h
Piper Sandler Upgrades CAVA Group (CAVA)
Fintel reports that on February 28, 2025, Piper Sandler upgraded their outlook for CAVA Group (NYSE:CAVA) from Neutral to ...
Kymera Therapeutics (KYMR) Receives a Buy from Piper Sandler
Piper Sandler analyst Edward Tenthoff reiterated a Buy rating on Kymera Therapeutics (KYMR – Research Report) today and set a price target of ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Iovance Biotherapeutics (IOVA), Xencor (XNCR) and Merus (MRUS)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Iovance Biotherapeutics (IOVA – Research ...
Hosted on MSN20h
Piper Sandler Downgrades Arhaus (ARHS)
Fintel reports that on February 27, 2025, Piper Sandler downgraded their outlook for Arhaus (NasdaqGS:ARHS) from Overweight ...